
Dear readers! In September the CeMAT RUSSIA exhibition was held, which showed everyone that innovations and robotics are increasingly penetrating the logistics industry. We can safely say that many technologies are tested here, and only then they go out into the world. However, it is not only CeMAT RUSSIA that demonstrates the prevalence of the digital agenda.
Dear readers! This is the ninth issue of the journal, which turned out to be very rich and diverse. Traditionally, the issue is opened by an analyst. The material by Alina Nasyrova from the Market Guide Agency, dedicated to investments in warehouse complexes in Russia, recalls the importance of developing logistics infrastructure for the integrated development of regions.
Dear readers! We present to your attention the eighth issue of the magazine and its materials.
Rigla Pharmacy Chain is at top of the rating of the most influential Russian pharmaceutical market participants in 2017 prepared by the analytics company Battersea Marketing with the assistance of the consulting company KPMG.
Group 36,6 is ranked No.2 and Doktor Stoletov & Ozerki is ranked No. 3 in the rating.
Alexander Filippov, the General Director of Rigla Pharmacy Chain, was presented with the winner’s certificate at the official ceremony in Moscow on February 15.
“It is a pleasure to know that in the opinion of the expert community, Rigla Pharmacy Chain heads the rating of the most influential pharmacy chain for the second consecutive year. Nowadays many companies experience to a degree difficulties in their business. I wish that all players of the pharmaceutical market in 2018 overcome such difficulties and that regardless of the market segment we all could develop at the prospective market”, - Alexander Filippov said.
Rigla was recognized as the most influential pharmacy chain among 50 companies following the voting of 525 experts from 33 cities in all federal regions of the Russian Federation - representatives of manufacturing, distribution and retail sectors of the pharmaceutical market, public sector and scientific sector.
The rating includes eleven categories: “Statesman / Public Person”, “Industry or Public Association”, “Local Manufacturer”, “Foreign Manufacturer”, “Distributor”, “Pharmacy Chain”, “Periodical Pharmaceutical Industry Publication”, “Website”, “Consumer Healthcare”, “Prescription Product”.